Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Synthetic Biologics Inc.

www.syntheticbiologics.com

Latest From Synthetic Biologics Inc.

Keeping Track: CDER Approves Its First Two Novel Agents Of 2019

The latest drug development news and highlights from our US FDA Performance Tracker.
US FDA Performance Tracker Drug Review

Microbiome, Clinical Trial Enrichment Among Question Marks As US FDA Weighs Guidance On Non-Traditional Infectious Disease Treatment

Discussions among panelists at US FDA meeting reveal lack of consensus in many key areas. 

Research & Development Infectious Diseases

Keeping Track: Good News/Bad News For Pfizer; Filings For Brexanolone, Risankizumab

The latest US drug development news and highlights from our Performance Tracker.
Drug Review Regulation

Pipeline Watch: Phase III Starts With VX-445, Reproxalap And AVXS-101

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Pipex Therapeutics Inc.
  • Pipex Pharmaceuticals Inc.
  • Sheffied Pharmaceuticals Inc.
  • Adeona Pharmaceuticals Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Synthetic Biologics Inc.
  • Senior Management
  • Steven Shallcross, Interim CEO & CFO
    Michael Kaleko, MD, PhD, SVP, R&D
    Joseph Sliman, MD, CMO
  • Contact Info
  • Synthetic Biologics Inc.
    Phone: (301) 417-4364
    9605 Medical Center Dr., Ste. 270
    Rockville, MD 20850
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register